DAGLA Peptide | 46-829P

DAGLA Peptide | 46-829P | Gentaur UK, US & Europe Distribution

Short Description: DAGLA Peptide

Species: Human

Location: DAGLA peptide corresponds to 12 amino acids of DAGLA.

Tested Application: Bl

Application: DAGLA Peptide is used for blocking the activity of DAGLA antibody (catalog number 46-829). The DAGLA antibody ships at 0.5 mg/mL and the DAGLA Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Physical State: Lyophilized

Buffer: DAGLA peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: DAGLA

Alternate Names: NSDDR, C11orf11, DAGLALPHA, DAGL(ALPHA), KIAA0659, NSDDR, Sn1-specific diacylglycerol lipase alpha, Neural stem cell-derived dendrite regulator, DGL-alpha

NCBI Gene ID: 747

User Note: N/A

NCBI Official Name: Diacylglycerol Lipase, Alpha

Background: N/A

Disclaimer: This product is for research use only.